LET'S TALK ABOUT COST.

LIVE

Serial Number

87528877

Owner

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Attorney

B. Brett Heavner

First Use Date

Jul 12, 2017

Filing Date

Jul 14, 2017

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

LET'S TALK ABOUT COST. Trademark

Serial Number: 87528877 • Registration: 6195507

LET'S TALK ABOUT COST. is a trademark filed by PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA on July 14, 2017. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Trademark Classes

Class 9 - Computers & Electronics

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Class 41 - Education & Entertainment

Education; providing of training; entertainment; sporting and cultural activities

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Class 35 - Advertising & Business

Advertising; business management; business administration; office functions

Owner Contact Info

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (85 trademarks)

WASHINGTON, DC 20005

Entity Type: 03

Legal Representation

Attorney of Record

B. Brett Heavner

2,892 trademarks filed View all →

Correspondence Address

B. Brett Heavner Finnegan, Henderson, Farabow, Garrett & Dunner LLP

901 New York Avenue NW

Washington, DC 20001

United States

Trademark Details

Filing Date

July 14, 2017

Registration Date

November 10, 2020

First Use Anywhere

July 12, 2017

First Use in Commerce

July 12, 2017

Published for Opposition

December 4, 2018

Goods & Services

Providing a website featuring non-downloadable publications in the nature of fact sheets, reports, articles, and informational brochures featuring graphic art work regarding biopharmaceuticals and the biopharmaceutical industry

Association services, namely, promoting the interests of research-based prescription drug manufacturers

Electronic downloadable publications in the nature of fact sheets, reports, and informational brochures featuring graphic art work regarding biopharmaceuticals and the biopharmaceutical industry

Providing online information regarding medical and scientific research in the field of biopharmaceuticals; providing online information on biopharmaceutical research

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Nov 10, 2025 REM1

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 7, 2024 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 7, 2024 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 7, 2024 REAP

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Mar 7, 2024 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Mar 7, 2024 COAR

REGISTERED-PRINCIPAL REGISTER

Nov 10, 2020 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Oct 7, 2020 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Oct 6, 2020 CNPR

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 5, 2020 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 5, 2020 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 28, 2020 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 26, 2020 GNRN

NON-FINAL ACTION E-MAILED

Mar 26, 2020 GNRT

SU - NON-FINAL ACTION - WRITTEN

Mar 26, 2020 CNRT

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 16, 2020 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 16, 2020 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 16, 2020 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 16, 2019 GNRN

NON-FINAL ACTION E-MAILED

Sep 16, 2019 GNRT

SU - NON-FINAL ACTION - WRITTEN

Sep 16, 2019 CNRT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 29, 2019 EXRA

STATEMENT OF USE PROCESSING COMPLETE

Aug 28, 2019 SUPC

SOU EXTENSION 1 GRANTED

Aug 28, 2019 EX1G

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Aug 27, 2019 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Aug 27, 2019 REAP

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 27, 2019 TROA

ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST

Jul 29, 2019 INCE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jul 29, 2019 AITU

USE AMENDMENT FILED

Jul 23, 2019 IUAF

SOU EXTENSION 1 FILED

Jul 23, 2019 EXT1

SOU TEAS EXTENSION RECEIVED

Jul 23, 2019 EEXT

TEAS STATEMENT OF USE RECEIVED

Jul 23, 2019 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jan 29, 2019 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 4, 2018 NPUB

PUBLISHED FOR OPPOSITION

Dec 4, 2018 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 14, 2018 NONP

ASSIGNED TO LIE

Oct 27, 2018 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 15, 2018 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 15, 2018 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 15, 2018 CRFA

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Oct 15, 2018 ERFR

NOTIFICATION OF FINAL REFUSAL EMAILED

Apr 13, 2018 GNFN

FINAL REFUSAL E-MAILED

Apr 13, 2018 GNFR

FINAL REFUSAL WRITTEN

Apr 13, 2018 CNFR

ASSIGNED TO EXAMINER

Apr 13, 2018 DOCK

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 12, 2018 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 12, 2018 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 12, 2018 TROA

ASSIGNED TO EXAMINER

Nov 27, 2017 DOCK

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 12, 2017 GNRN

NON-FINAL ACTION E-MAILED

Oct 12, 2017 GNRT

NON-FINAL ACTION WRITTEN

Oct 12, 2017 CNRT

ASSIGNED TO EXAMINER

Oct 12, 2017 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 21, 2017 NWOS

NEW APPLICATION ENTERED

Jul 18, 2017 NWAP

Related Trademarks

More from this Owner

Serial #97407646

WORKING FOR CURES

More in Same Class

SAMSUNG CLOUD CONNECT

GFC

CREATE BANG & OLUFSEN

VS ARENA

FANTASY LEGEND STUDIOS

SHADOWMAKER